The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy
Abstract Background Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulopathy worldwide, and lacks the effective treatment. The study was aimed to investigate the clinical efficacy of fluticasone propionate aerosol combined with angiotensin converting enzyme inhibitor / angiotens...
Main Authors: | Liping Sun, Xinyi Zi, Zhen Wang, Xinzhou Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-023-03106-4 |
Similar Items
-
Efficacy of intranasal fluticasone propionate nano nasal spray in management of chronic rhinitis: a randomized clinical trial
by: Yasir Mehmood, et al.
Published: (2023-01-01) -
An efficacy and safety evaluation of montelukast + fluticasone propionate vs. fluticasone propionate in the treatment of cough variant asthma in children: a meta-analysis
by: Zhengbo Wei, et al.
Published: (2023-12-01) -
Efficacy and safety of fluticasone propionate nasal spray in treatment ofadenoidal hypertrophic snoring in children
by: Hanzhong Duan, et al.
Published: (2023-01-01) -
Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
by: Byeong Yun Yang, et al.
Published: (2012-09-01) -
Fluticasone propionate for external use: pharmacological properties and clinical effectiveness
by: E. V. Dvoriankova
Published: (2021-06-01)